Glaxo buys rights to experimental diabetes drug
557027
Drug maker GlaxoSmithKline, which has co-US headquarters in Philadelphia and Research Triangle Park, has acquired exclusive rights to a potential diabetes treatment in a deal that could be worth more than $180 million.
589861
Swiss drug giant Novartis SA said yesterday it is spending $4 million to fund scientists performing diabetes research at Harvard University, the Massachusetts Institute of Technology, and the Broad Institute, and will make the findings public for other scientists to use.
115039
Deal makers powered ahead, even as one pending merger faced a regulatory hurdle. Makers of diabetes drugs agreed to use the most severe warning on labels, and broadcasters won a favorable federal court ruling regarding obscenities.
203734
GlaxoSmithKline Plc  has signed a  drug discovery deal with U.S. biotech firm ChemoCentryx  potentially worth up to $1.5 billion in milestone payments and  research funding to the privately owned group.
723247
GlaxoSmithKline Plc (GSK.L: Quote, Profile, Research) has agreed to release all clinical studies of its drugs to settle a lawsuit that accused it of withholding negative information about the antidepressant Paxil, the New York
690168
LONDON -- GlaxoSmithKline PLC, the world's second-largest pharmaceutical company, said Monday that it expects to introduce five new cancer treatments through 2010.
714702
British pharmaceutical group GlaxoSmithKline said that it had agreed to supply the Russian government with HIV drugs at discounted prices.
6408
GlaxoSmithKline has agreed to disclose information on all clinical studies of its drugs to settle a lawsuit that accused it of withholding negative information about the antidepressant Paxil, the New York Attorney General&#39;s office says
619755
British pharmaceuticals giant GlaxoSmithKline today agreed to make public information about all its clinical drug trials following accusations that it misled doctors about the safety of an anti-depressant for children.
251574
U.S. health regulators have approved GlaxoSmithKline Plc's   pill Tykerb for patients with advanced breast cancer after other treatments have failed, a company spokeswoman said on Tuesday.
724758
GlaxoSmithKline Plc won approval to  sell an over-the-counter weight loss drug called Alli in the  United States, the company and U.S. health officials said on  Wednesday.
170831
GlaxoSmithKline Plc  has bought  global rights to Danish biotech company Genmab's  most  promising new drug, a treatment for leukemia, in a record deal  worth up to $2.1 billion, the two firms said on Tuesday.
227772
The pharmaceutical sells European rights to a promising asthma drug.
1595
The pharmaceutical giant GlaxoSmithKline has agreed to settle consumer fraud charges by posting online both negative and positive results from its clinical drug trials, a practice that New York Attorney General Eliot Spitzer said should have been made
279854
erck &amp; Company has obtained rights to license an experimental drug to treat obesity that has generated scientific interest because it is based on a hormone used by the body to signal that it has eaten enough.
275372
Drugmakers are working on experimental diabetes drugs using a novel mechanism to help flush excess blood sugar out of the body, according to results of small studies presented at a medical meeting on Sunday.
449782
A GlaxoSmithKline blood pressure  medicine proved significantly better in keeping blood sugar  levels from rising in diabetics than another widely used member  of the beta blocker family of hypertension drugs, according to  a large clinical trial.